The Supreme Court has unanimously ruled companies cannot patent isolated human genes. The case concerned patents held by Myriad Genetics on genes linked to breast and ovarian cancer. The genes have been in the public eye since Angelina Jolie said she underwent a double mastectomy after genetic testing revealed her elevated risk of breast cancer. The test she took cost thousands of dollars, but that could now change under the court’s decision.